Beta adrenergic blockers

DRUG2 trials

Sponsors

NYU Langone Health, National Institute of Cardiology, Warsaw, Poland

Conditions

Cardiovascular DiseasesHeart DiseasesHeart FailureHeart Failure, CongestiveMyocardial Infarction

Phase 3

Occluded Artery Trial (OAT)

CompletedNCT00004562

NYU Langone HealthCardiovascular Diseases, Heart Diseases, Heart Failure +2

Start: 1999-09-30End: 2011-06-30Updated: 2014-04-21

Unknown Phase

Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment

TerminatedNCT00968383

National Institute of Cardiology, Warsaw, PolandCardiovascular Diseases, Heart Diseases, Heart Failure +1

Start: 2009-09-30End: 2012-12-31Updated: 2015-05-14

Related Papers

Relationship of obesity to adverse events in myocardial infarction patients without primary percutaneous coronary intervention: results from the Occluded Artery Trial (OAT)

Current Medical Research and Opinion2019-04-056 citations

Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial.

2010-06-1453 citations

Quality of life after late invasive therapy for occluded arteries.

2009-02-0126 citations

Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.

2008-10-019 citations